Medprin Regenerative Valuation
| 301033 Stock | 48.63 0.03 0.06% |
At this time, the firm appears to be overvalued. Medprin Regenerative secures a last-minute Real Value of USD39.09 per share. The latest price of the firm is USD48.63. Our model forecasts the value of Medprin Regenerative from analyzing the firm fundamentals such as Return On Equity of 0.11, current valuation of 3.05 B, and Profit Margin of 0.25 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 4.8741 | Enterprise Value 3.1 B | Enterprise Value Ebitda 37.2012 | Price Sales 11.7119 | Trailing PE 46.7308 |
Overvalued
Today
Please note that Medprin Regenerative's price fluctuation is very steady at this time. Calculation of the real value of Medprin Regenerative is based on 3 months time horizon. Increasing Medprin Regenerative's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Medprin Regenerative is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medprin Stock. However, Medprin Regenerative's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 48.63 | Real 39.09 | Hype 48.7 | Naive 50.29 |
The real value of Medprin Stock, also known as its intrinsic value, is the underlying worth of Medprin Regenerative Company, which is reflected in its stock price. It is based on Medprin Regenerative's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Medprin Regenerative's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Medprin Regenerative Medical helps investors to forecast how Medprin stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medprin Regenerative more accurately as focusing exclusively on Medprin Regenerative's fundamentals will not take into account other important factors: Medprin Regenerative Cash |
|
Medprin Regenerative Total Value Analysis
Medprin Regenerative Medical is presently estimated to have takeover price of 3.05 B with market capitalization of 3.23 B, debt of 151.11 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Medprin Regenerative fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.05 B | 3.23 B | 151.11 M |
Medprin Regenerative Investor Information
About 53.0% of the company shares are owned by insiders or employees . The book value of Medprin Regenerative was presently reported as 10.09. The company last dividend was issued on the 26th of June 2024. Based on the measurements of operating efficiency obtained from Medprin Regenerative's historical financial statements, Medprin Regenerative Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 63.3 M | 123.8 M |
|
| |||||
| Operating Income | 38.7 M | 52 M |
|
|
Medprin Regenerative Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Medprin Regenerative has an asset utilization ratio of 29.34 percent. This suggests that the Company is making USD0.29 for each dollar of assets. An increasing asset utilization means that Medprin Regenerative Medical is more efficient with each dollar of assets it utilizes for everyday operations.Medprin Regenerative Ownership Allocation
Medprin Regenerative maintains a total of 66.52 Million outstanding shares. Medprin Regenerative Medical holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Medprin Regenerative Profitability Analysis
The company reported the revenue of 230.87 M. Net Income was 40.88 M with profit before overhead, payroll, taxes, and interest of 220.53 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Medprin Regenerative's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Medprin Regenerative and how it compares across the competition.
About Medprin Regenerative Valuation
The stock valuation mechanism determines Medprin Regenerative's current worth on a weekly basis. Our valuation model uses a comparative analysis of Medprin Regenerative. We calculate exposure to Medprin Regenerative's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medprin Regenerative's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 217.7 M | 149.6 M |
Medprin Regenerative Quarterly Retained Earnings |
|
Complementary Tools for Medprin Stock analysis
When running Medprin Regenerative's price analysis, check to measure Medprin Regenerative's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medprin Regenerative is operating at the current time. Most of Medprin Regenerative's value examination focuses on studying past and present price action to predict the probability of Medprin Regenerative's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medprin Regenerative's price. Additionally, you may evaluate how the addition of Medprin Regenerative to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |